SK4262002A3 - The use of a peptide coded by the prv-1 gene or by a fragment thereof in production of a medicament acting as a growth factor - Google Patents

The use of a peptide coded by the prv-1 gene or by a fragment thereof in production of a medicament acting as a growth factor Download PDF

Info

Publication number
SK4262002A3
SK4262002A3 SK426-2002A SK4262002A SK4262002A3 SK 4262002 A3 SK4262002 A3 SK 4262002A3 SK 4262002 A SK4262002 A SK 4262002A SK 4262002 A3 SK4262002 A3 SK 4262002A3
Authority
SK
Slovakia
Prior art keywords
until
amino acids
sequence seq
seq
nucleotides
Prior art date
Application number
SK426-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Heike Pahl
Original Assignee
Universitaetsklinikum Freiburg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitaetsklinikum Freiburg filed Critical Universitaetsklinikum Freiburg
Publication of SK4262002A3 publication Critical patent/SK4262002A3/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurosurgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
SK426-2002A 1999-09-30 2000-09-29 The use of a peptide coded by the prv-1 gene or by a fragment thereof in production of a medicament acting as a growth factor SK4262002A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19947010A DE19947010A1 (de) 1999-09-30 1999-09-30 Das Gen PRV-1 und dessen Verwendung
PCT/EP2000/009594 WO2001023554A1 (de) 1999-09-30 2000-09-29 Das gen prv-1 und dessen verwendung

Publications (1)

Publication Number Publication Date
SK4262002A3 true SK4262002A3 (en) 2002-09-10

Family

ID=7923937

Family Applications (1)

Application Number Title Priority Date Filing Date
SK426-2002A SK4262002A3 (en) 1999-09-30 2000-09-29 The use of a peptide coded by the prv-1 gene or by a fragment thereof in production of a medicament acting as a growth factor

Country Status (21)

Country Link
EP (1) EP1220920A1 (ru)
JP (1) JP2003510077A (ru)
KR (1) KR20020047191A (ru)
CN (1) CN1377408A (ru)
AU (1) AU1132401A (ru)
BG (1) BG106554A (ru)
BR (1) BR0014444A (ru)
CA (1) CA2387702A1 (ru)
CZ (1) CZ20021094A3 (ru)
DE (1) DE19947010A1 (ru)
EA (1) EA200200286A1 (ru)
EE (1) EE200200168A (ru)
HR (1) HRP20020269A2 (ru)
HU (1) HUP0203080A2 (ru)
IL (1) IL148770A0 (ru)
MX (1) MXPA02002800A (ru)
NO (1) NO20021498L (ru)
PL (1) PL354184A1 (ru)
SK (1) SK4262002A3 (ru)
WO (1) WO2001023554A1 (ru)
ZA (1) ZA200202379B (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158599A0 (en) * 2003-10-26 2004-05-12 Yeda Res & Dev Methods of modulating hematopoiesis
KR102115438B1 (ko) 2012-05-21 2020-05-27 제넨테크, 인크. 혈액-뇌 장벽 수송의 안전성을 개선하는 방법
US20210147807A1 (en) * 2017-06-14 2021-05-20 Helmholtz Zentrum Munchen - Deutsches Forschungszentrum Fur Gesundheit Und Umwelt (Gmbh) Methods for purifying endoderm and pancreatic endoderm cells derived from human embryonic stem cells

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2289118A1 (en) * 1997-05-06 1998-11-12 Zymogenetics, Inc. Novel tumor antigens
CA2328895A1 (en) * 1998-06-02 1999-12-09 Genentech, Inc. Secreted and transmembrane polypeptides and nucleic acids encoding the same
DE19849044A1 (de) * 1998-10-23 2000-04-27 Univ Ludwigs Albert Das Gen PRV-1 und dessen Verwendung
IL142794A0 (en) * 1998-12-16 2002-03-10 Genentech Inc Secreted and transmembrane polypeptides and nucleic acids encoding the same

Also Published As

Publication number Publication date
HUP0203080A2 (hu) 2002-12-28
PL354184A1 (en) 2003-12-29
HRP20020269A2 (en) 2003-06-30
KR20020047191A (ko) 2002-06-21
ZA200202379B (en) 2003-10-29
CZ20021094A3 (cs) 2002-06-12
WO2001023554A1 (de) 2001-04-05
DE19947010A1 (de) 2001-04-05
EP1220920A1 (de) 2002-07-10
NO20021498D0 (no) 2002-03-26
IL148770A0 (en) 2002-09-12
CA2387702A1 (en) 2001-04-05
BG106554A (bg) 2003-01-31
JP2003510077A (ja) 2003-03-18
NO20021498L (no) 2002-05-23
BR0014444A (pt) 2002-06-11
MXPA02002800A (es) 2002-07-22
CN1377408A (zh) 2002-10-30
AU1132401A (en) 2001-04-30
EE200200168A (et) 2003-04-15
EA200200286A1 (ru) 2002-12-26

Similar Documents

Publication Publication Date Title
JP2002516103A (ja) インターロイキン２１およびインターロイキン２２
JP2001524814A (ja) ２８種類のヒト分泌タンパク質
JP2005218453A (ja) ８７個のヒト分泌タンパク質
JPH07505139A (ja) 肝成長因子レセプター
KR20030093316A (ko) 혈관 내피 성장 인자 ２
JPH07107983A (ja) Ｊａｋキナーゼおよびサイトカインシグナル形質導入の調節
JPH11505417A (ja) ヒトケモカインベータ−８、ケモカインベータ−１、およびマクロファージ炎症性タンパク質−４
JPH06506596A (ja) インターロイキン−８受容体及び関連分子及び方法
US6166186A (en) Monoclonal antibody which binds to a human-Th2-specific protein and hybridoma
KR100262420B1 (ko) 바이러스, 특히 레트로바이러스의 복제를 억제하기 위한 "면역결핍-바이러스 억제 림포카인(아이에스엘)"의 용도
WO2011091716A9 (zh) 表皮生长因子受体变异体
SK4262002A3 (en) The use of a peptide coded by the prv-1 gene or by a fragment thereof in production of a medicament acting as a growth factor
WO1998017800A1 (fr) Larc, nouvelle chimiokine cc humaine
JPH11512610A (ja) 短縮形ケモカインβ−８
US6686153B1 (en) PRV-1 gene and the use thereof
KR20010043088A (ko) 신규인 폴리펩티드, 그 폴리펩티드를 코드화하는 ｃＤＮＡ및 그 용도
KR100260272B1 (ko) Tpo활성을 갖는 단백질의 아미노산을 코딩하는 염기 서열을 포함하는 dna
JP2002502601A (ja) 樹状富化分泌リンパ球活性化分子
JP2002503112A (ja) 哺乳類分泌ペプチド−９
WO1999032609A1 (en) Molecules associated with the human fused gene
JPH11302298A (ja) ヒトｃｃ型ケモカインｉｌｃ
CA2233367A1 (en) Short forms of chemokine .beta.-8
JP2002510192A (ja) １８６個のヒトの分泌タンパク質